Logo image of OBLG

OBLONG INC (OBLG) Stock Fundamental Analysis

NASDAQ:OBLG - Nasdaq - US6744343038 - Common Stock - Currency: USD

4.5  -0.35 (-7.22%)

Fundamental Rating

2

Overall OBLG gets a fundamental rating of 2 out of 10. We evaluated OBLG against 282 industry peers in the Software industry. OBLG has a great financial health rating, but its profitability evaluates not so good. OBLG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year OBLG has reported negative net income.
In the past year OBLG has reported a negative cash flow from operations.
OBLG had negative earnings in each of the past 5 years.
OBLG had a negative operating cash flow in each of the past 5 years.
OBLG Yearly Net Income VS EBIT VS OCF VS FCFOBLG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

OBLG has a worse Return On Assets (-265.19%) than 95.39% of its industry peers.
The Return On Equity of OBLG (-376.42%) is worse than 83.69% of its industry peers.
Industry RankSector Rank
ROA -265.19%
ROE -376.42%
ROIC N/A
ROA(3y)-237.61%
ROA(5y)-155.05%
ROE(3y)-345.63%
ROE(5y)-222.48%
ROIC(3y)N/A
ROIC(5y)N/A
OBLG Yearly ROA, ROE, ROICOBLG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

The Gross Margin of OBLG (24.56%) is worse than 80.50% of its industry peers.
In the last couple of years the Gross Margin of OBLG has declined.
OBLG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.56%
GM growth 5Y-19.85%
OBLG Yearly Profit, Operating, Gross MarginsOBLG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

7

2. Health

2.1 Basic Checks

OBLG does not have a ROIC to compare to the WACC, probably because it is not profitable.
OBLG has less shares outstanding than it did 1 year ago.
OBLG has more shares outstanding than it did 5 years ago.
There is no outstanding debt for OBLG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OBLG Yearly Shares OutstandingOBLG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
OBLG Yearly Total Debt VS Total AssetsOBLG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

OBLG has an Altman-Z score of -66.52. This is a bad value and indicates that OBLG is not financially healthy and even has some risk of bankruptcy.
OBLG has a Altman-Z score of -66.52. This is amonst the worse of the industry: OBLG underperforms 96.81% of its industry peers.
There is no outstanding debt for OBLG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -66.52
ROIC/WACCN/A
WACC10.76%
OBLG Yearly LT Debt VS Equity VS FCFOBLG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 3.38 indicates that OBLG has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.38, OBLG belongs to the best of the industry, outperforming 80.50% of the companies in the same industry.
OBLG has a Quick Ratio of 3.38. This indicates that OBLG is financially healthy and has no problem in meeting its short term obligations.
OBLG's Quick ratio of 3.38 is amongst the best of the industry. OBLG outperforms 80.50% of its industry peers.
Industry RankSector Rank
Current Ratio 3.38
Quick Ratio 3.38
OBLG Yearly Current Assets VS Current LiabilitesOBLG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for OBLG have decreased strongly by -1062.52% in the last year.
Looking at the last year, OBLG shows a very negative growth in Revenue. The Revenue has decreased by -30.18% in the last year.
The Revenue for OBLG have been decreasing by -28.62% on average. This is quite bad
EPS 1Y (TTM)-1062.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-762.12%
Revenue 1Y (TTM)-30.18%
Revenue growth 3Y-32.52%
Revenue growth 5Y-28.62%
Sales Q2Q%-0.64%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OBLG Yearly Revenue VS EstimatesOBLG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
OBLG Yearly EPS VS EstimatesOBLG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 -200 -400 -600 -800 -1K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OBLG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OBLG Price Earnings VS Forward Price EarningsOBLG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OBLG Per share dataOBLG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OBLG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OBLONG INC

NASDAQ:OBLG (7/14/2025, 8:00:02 PM)

4.5

-0.35 (-7.22%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-06 2025-05-06
Earnings (Next)08-05 2025-08-05
Inst Owners2.16%
Inst Owner Change0%
Ins Owners17.65%
Ins Owner Change0%
Market Cap7.16M
Analysts82.86
Price TargetN/A
Short Float %15.34%
Short Ratio0.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.01
P/FCF N/A
P/OCF N/A
P/B 2.14
P/tB 2.14
EV/EBITDA N/A
EPS(TTM)-14.39
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.17
FCFYN/A
OCF(TTM)-2.17
OCFYN/A
SpS1.49
BVpS2.11
TBVpS2.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -265.19%
ROE -376.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.56%
FCFM N/A
ROA(3y)-237.61%
ROA(5y)-155.05%
ROE(3y)-345.63%
ROE(5y)-222.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.56%
GM growth 5Y-19.85%
F-Score3
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.38
Quick Ratio 3.38
Altman-Z -66.52
F-Score3
WACC10.76%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1062.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-762.12%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.18%
Revenue growth 3Y-32.52%
Revenue growth 5Y-28.62%
Sales Q2Q%-0.64%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y20.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.92%
OCF growth 3YN/A
OCF growth 5YN/A